1. ALLA AKTIER
  2. NYHETER
  3. VIMIAN

Vimian

Nyheter Vimian Nyheter alla bolag

Nomination Committee for Vimian’s 2023 Annual General Meeting

MARKN.

The Nomination Committee for Vimian Group has been appointed.

Vimian’s Nomination Committee for the 2023 Annual General Meeting has been appointed based on the ownership structure as of September 30, 2022.

The Nomination Committee comprises the following members:

Håkan Håkansson, Fidelio Capital

Erik Ståhl Hallengren, SEB Fonder

Angelica Hanson, AMF Pension & Fonder

Gabriel Fitzgerald, Chairman of the Board

Chairman of the Nomination Committee will be appointed at the Nomination Committee’s first meeting.

The Annual General Meeting of Vimian Group will be held on June 1, 2023. Shareholders who would like to submit proposals to the Nomination Committee for the 2023 Annual General Meeting can submit such via email to generalmeetings@vimian.com no later than April 6, 2023

For further information, please contact:

Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability
maria.tullberg@vimian.com
+46 736 26 88 86

About Vimian

Vimian is a global, fast-growing group of innovation-driven companies with a shared passion for making a positive impact through improving animal health. Together, we put science, technology and our customers’ needs at the centre of everything we do to deliver effective solutions to veterinary professionals, labs and pet parents around the world. We bring together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. Our group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are as passionate about supporting leadership within our existing businesses, as we are about welcoming new partners to the Vimian family – together helping us make an even greater impact by improving animal health. Headquartered in Stockholm, Sweden, Vimian and our family of companies reach over 15,000 customers in +150 markets, employ more than 700 people and have a combined annual turnover of approximately EUR 170 million. FNCA Sweden AB is appointed the Company’s Certified Adviser, info@fnca.se. For more information, please visit: www.vimian.com.

Attachments

Nomination Committee for Vimian’s 2023 Annual General Meeting

Datum 2022-10-24, kl 10:00
Källa MFN
Bifogade filer
Nomination Committee for Vimian’s 2023 Annual General Meeting
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!